BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19745777)

  • 1. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.
    Tanno S; Nakano Y; Koizumi K; Sugiyama Y; Nakamura K; Sasajima J; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Okumura T; Obara T; Kohgo Y
    Pancreas; 2010 Jan; 39(1):36-40. PubMed ID: 19745777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
    Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.
    Rautou PE; Lévy P; Vullierme MP; O'Toole D; Couvelard A; Cazals-Hatem D; Palazzo L; Aubert A; Sauvanet A; Hammel P; Hentic O; Rebours V; Pelletier AL; Maire F; Ruszniewski P
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):807-14. PubMed ID: 18304885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.
    Maguchi H; Tanno S; Mizuno N; Hanada K; Kobayashi G; Hatori T; Sadakari Y; Yamaguchi T; Tobita K; Doi R; Yanagisawa A; Tanaka M
    Pancreas; 2011 Apr; 40(3):364-70. PubMed ID: 21289527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary findings assist in predicting enlargement of intraductal papillary mucinous neoplasms of the pancreas.
    Matsuzaki J; Suzuki H; Okuda S; Tanimoto A; Asakura K; Fukuhara S; Okada S; Hirata K; Mori H; Masaoka T; Higuchi H; Hozawa S; Kuribayashi S; Takebayashi T; Hibi T
    Clin Gastroenterol Hepatol; 2013 May; 11(5):548-54. PubMed ID: 23220169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients.
    Woo SM; Ryu JK; Lee SH; Yoon WJ; Kim YT; Yoon YB
    Br J Surg; 2009 Apr; 96(4):405-11. PubMed ID: 19283746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
    Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
    Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients.
    Gill KR; Pelaez-Luna M; Keaveny A; Woodward TA; Wallace MB; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB; Raimondo M
    Am J Gastroenterol; 2009 May; 104(5):1256-61. PubMed ID: 19352341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
    Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.